ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PASW vs PG // EV/EBITDA & P/E VALUATION

Ping An Biomedical Co. Ltd. (Class A) (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: PASW 0 — PG 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PASW VS. PG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PASW PG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 2.80% 51.20% -48.40 PG /gross-margins <GO>
Return on Invested Capital (ROIC) — 25.40% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 16.2x — TIE /valuation <GO>
Free Cash Flow Yield -5.77% 3.77% -9.54 PG /fcf-yield <GO>
Operating Margin -43.10% 24.30% -67.40 PG /operating-margins <GO>
Net Profit Margin -37.60% 19.00% -56.60 PG /net-margins <GO>
Revenue Growth (YoY) — 0.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.65% -2.65 PG /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 7/9 -6.00 PG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.4 60.3 -9.90 PG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.87 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 21.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $15.6M $372.21B -$372.20B PG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PASW REV PG REV PASW GROSS % PG GROSS % PASW FCF PG FCF
FY 2025 $4.8M $84.28B 2.8% 51.2% -$902.9K $14.04B
FY 2024 — $84.04B — 51.4% — $16.52B
FY 2023 — $82.01B — — — $13.16B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PASW // BETA —
PG // BETA 0.87